Among the myriad of stock recommendations from the renowned Jim Cramer on CNBC’s “Mad Money Lightning Round,” he hailed Vertiv Holdings Co VRT as “one of the great performers of our time.”
Vertiv is poised to unveil its much-anticipated fourth-quarter results before the market opens on Feb. 21, 2024. Analysts are anticipating a quarterly earnings surge to 53 cents per share, compared to 28 cents per share in the corresponding period last year. Furthermore, the company is projected to report revenue of $1.88 billion, signifying a substantial increase from $1.65 billion in the year-earlier quarter.
Cramer also advocated sticking with General Dynamics Corporation GD while commending its CEO. General Dynamics recently surpassed expectations with fourth-quarter sales results, posting a remarkable 7.5% year-over-year revenue growth to $11.67 billion, outperforming the consensus of $11.37 billion.
However, when asked about C3.ai, Inc. AI, Cramer expressed skepticism due to the absence of earnings. “That’s Tom Siebel [CEO of C3.ai], I happen to like Tom. I don’t see any earnings there,” Cramer noted. “I can’t recommend a stock that has no earnings.”
In contrast, C3.ai announced its upcoming annual AI conference, C3 Transform 2024, scheduled from March 5 to March 7, which is expected to spotlight the prodigious impact of generative AI in delivering productivity and efficiency benefits across various industries.
Don’t forget to check out our premarket coverage here.
Altimmune, Inc. ALT, according to Cramer, is a “good spec, but that’s what it is, it’s spec.”
Goldman Sachs analyst Corinne Jenkins recently reinstated coverage on Altimmune with a Neutral rating and announced a $13 price target.
On a different note, Cramer recommended investing in Affirm Holdings, Inc. AFRM, deeming it “a winner.” Affirm reported a 48% year-over-year surge in fiscal second-quarter revenue to $591.1 million, surpassing the consensus estimate of $520.62 million. Additionally, the company reported a loss of 54 cents per share, outperforming analyst estimates for a loss of 72 cents per share.
Darling Ingredients Inc. DAR captivated Cramer’s interest, although he accentuated the persistent decline in its stock price. “It’s too inexpensive to go, I’m going to leave it like that,” he added.
Citigroup analyst Thomas Palmer recently initiated coverage on Darling Ingredients with a Neutral rating and announced a price target of $49.
Price Action:
- Shares of Vertiv Holdings fell 3.5% to close at $61.32 on Monday.
- General Dynamics shares fell 0.3% to $269.44 on Monday.
- C3.ai shares rose 9.5% to settle at $31.18 during Monday’s session.
- Shares of Altimmune fell 0.4% to close at $10.40 on Monday.
- Affirm shares rose 2.6% to settle at $45.00 on Monday.
- Shares of Darling Ingredients gained 3.7% to close at $43.10 during the session.
Now Read This: Over $15M Bet On Aon? Check Out These 3 Stocks Insiders Are Buying
Image: Shutterstock
